CDKN1A and cancer: To functionally address the involvement of p21 on the effect observed after expressing the reprogramming factors on cancer cells, we decided to reduce its expression by using an shRNA targeting CDKN1A. Lentiviral transduction of the A549-rtTA-OSKM cells with this plasmid caused a reduction on p21 mRNA and protein levels (Fig. 4B).